Description     Claims     Drawing  

WO2005030041A   [0015] 
GB0822817A   [0136] 

Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer   [0135] 
Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa   [0135] 
HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness   [0135] 
The causal relation between human papillomavirus and cervical cancer   [0135] 
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer   [0135] 
Analysis of deletion of the integrated human papillomavirus 16 sequence in cervical cancer: a rapid multiplex polymerase chain reaction approach   [0135] 
Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia   [0135] 
HPV type-distribution in women with and without cervical neoplastic diseases   [0135] 
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions   [0135] 
Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study   [0135] 
A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8   [0135] 
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix   [0135] 
Natural history of cervicovaginal papillomavirus infection in young women   [0135] 
Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities   [0135] 
Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer   [0135] 
Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas   [0135] 
Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis   [0135] 
Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes   [0135] 
Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?   [0135] 
Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines   [0135] 
Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells   [0135] 
Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping   [0135] 
Genomic changes and HPV type in cervical carcinoma   [0135] 
Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines   [0135] 
The burden of HPV-related cancers   [0135] 
Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique   [0135] 
RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses   [0135] 
The performance of the HPV16 real-time PCR integration assay   [0135] 
Human papillomavirus infection: biology, epidemiology, and prevention   [0135] 
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification   [0135] 
Human papillomavirus type 16 DNA sequence   [0135] 
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas   [0135] 
Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions   [0135] 
Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer   [0135] 
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide   [0135] 
Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix   [0135] 
A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques   [0135] 
Papillomaviruses and cancer: from basic studies to clinical application   [0135] 
Picogram per cell determination of DNA by flow cytofluorometry   [0135] 
Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union Cohort Study   [0135] 
Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set   [0135]